AIM-HI Beacon Award for Women Leaders in Oncology
The AIM-HI Beacon Award for Women Leaders in Oncology recognizes outstanding women leaders in all sectors of the health and life sciences industry who have made a significant impact on advancing cancer treatment, detection, and diagnosis for patients worldwide through development and commercialization of novel technologies and/or implementation of public policy.
The 2022 Beacon Award prize recipient will be honored and awarded an authentic gold medal at a Luncheon Award Ceremony at the National Press Club in Washington DC on October 22, 2022. In addition, AIM-HI will provide $20,000 for an Emerging Women Leaders Fellowship — named after the yearly Beacon Award recipient — to honor and support promising young women scholars from specific universities and institutions across the areas of cancer research, biotechnology, healthcare public policy, and entrepreneurship in healthcare & life sciences.
Nominees will have played an essential role in helping develop, approve and commercialize innovative cancer drugs, therapies or diagnostics and that are impacting patients’ lives or have significant promise to do so in the future. Two co-nominees may be considered if they demonstrate shared leadership responsibilities for the development of oncology discoveries, technologies and/or products.
Nominations from academia, the investment community, industry, government, or other organizations are welcome and require:
- Nominee’s CV (ten pages maximum) containing employment history, previous honors/awards and contact information (including cell phone)
- A Letter of Nomination (no more than 2,000 words) describing the Nominee’s success, barriers she overcame, contributions and impact she has made for cancer patients from commercialization of technology, product, and/or public policy. The letter should indicate the Nominator’s position and brief biographical information
- Nomination opens on July 1 and closes on August 31, 2022
All nomination information will be kept confidential, and be reviewed and evaluated by the distinguished Beacon Award Selection Committee, comprising of physician-scientists, successful entrepreneurs, and prominent business leaders in the health & life sciences industry. Nominations will be assessed according to the following criteria:
- Sustained commitment and leadership for cancer research, development and commercialization of innovative products
- Advocacy for and implementation of public policy to benefit cancer patients
- Encouragement, advocacy and inspiration of other women
- Impact on cancer patients, their families and community